Fenbufen
Fenbufen is a non-steroidal anti-inflammatory drug in the propionic acid derivatives class. (In Vitro) :Fenbufen (100-500 μM) improves the viability of apoptotic THP-1 cells treated with 25 μM Nigericin (HY-127019) . (In Vivo) :Fenbufenmay (1200 mg/kg; feed) does not cause gastric ulceration whilst inducing a near maximal inhibition of prostaglandin release in rats.Fenbufenmay (1200 mg/kg; p.o.; diet; for 10 days) blocks the hypertrophy of the heart but not that of the skeletal muscles.
Product Specifications
CAS Number
36330-85-5
Product Name Alternative
Fenbufen | Cinopal | Lederfen | CL-82204 | CL 82204 | CL82204
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO: 10 mM
Smiles
O=C (O) CCC (C1=CC=C (C2=CC=CC=C2) C=C1) =O
Molecular Formula
C16H14O3
Molecular Weight
254.28
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
4- ([1,1'-biphenyl]-4-yl) -4-oxobutanoic acid
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-Human CD52 Monoclonal Antibody (ABS0103), PerCP
SPRED1 (SPRED1, Sprouty-related, EVH1 domain-containing protein 1) (MaxLight 405)
SPRED1 (SPRED1, Sprouty-related, EVH1 domain-containing protein 1) (MaxLight 405)
Influenza A virus (H5N1) HA/Hemagglutinin Antibody